Mixed lichenoid and psoriasiform drug eruption induced by rifampicin
Feng X, Ye X, Xu J, Li C
The Australasian journal of dermatology · 2019-12
Abstract
Rifampicin is an essential first line anti-tuberculosis drug. However, several cases of adverse reactions associated with this drug have been reported, the most common of which are cutaneous drug reactions. We report a case of mixed lichenoid and psoriasiform drug eruption induced by rifampicin.
MeSH terms
- Humans
- Drug Eruptions
- Lichenoid Eruptions
- Psoriasis
- Rifampin
- Antitubercular Agents